Recent Research Analysts’ Ratings Updates for Olema Pharmaceuticals (OLMA)
Olema Pharmaceuticals (NASDAQ: OLMA) recently received a number of ratings updates from brokerages and research firms: 11/21/2025 – Olema Pharmaceuticals had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $26.00. They now have a “buy” rating on the stock. 11/18/2025 – Olema Pharmaceuticals had its price target raised […]
3 Dec 15:12 · The Cerbat Gem